Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 C 4 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
--(BUSINESS WIRE)--Sarepta Therapeutics ... inducement to employment to 8 individuals hired by Sarepta in March 2024. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). Read More
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2024 that were previously approved by the Compensation ... Read More
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The options were granted as material inducements to employment in accordance with Nasdaq Listing Rule 5635(c)(4). This press release contains ... particularly under the caption “Risk Factors ... Read More
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today ... Read More
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Viridian Therapeutics ... conditions of such Plan. The Inducement Grants were granted as an inducement material to these individuals entering into employment with Viridian in accordance with Nasdaq ... Read More
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4 ... of Akebia's inducement award program and a stock option agreement covering the grant. Akebia Therapeutics, Inc ... Read More
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 05, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics ... with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement grants consist of non-qualified stock options to ... Read More
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics ... an inducement material to the new employee entering employment with Mersana in accordance with Nasdaq Listing Rule 5635(c)(4). Read More
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The inducement awards were approved by the Compensation Committee of Voyager’s Board of Directors in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). The option award became ... Read More
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics ... inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4). Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus